Inborn errors of proline metabolism

被引:66
作者
Mitsubuchi, Hiroshi [1 ]
Nakamura, Kimitoshi [1 ]
Matsumoto, Shiro [1 ]
Endo, Fumio [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Pediat, Kumamoto 8608556, Japan
关键词
D O I
10.1093/jn/138.10.2016S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
L-Proline concentration is primarily related to the balance of enzymatic activities of proline dehydrogenase [proline oxidase (POX)] and Delta-1-pyrroline-5-carboxylate (P5C) reductase. As a result, P5C plays a pivotal role in maintaining the concentration of proline in body fluids and inborn errors of P5C metabolism lead to disturbance of proline metabolism. Several inborn errors of proline metabolism have been described. Hyperprolinemia type I (HPI) is a result of a deficiency in POX. The POX gene (PRODH is located on chromosome 22 (22q11.2) and this region is deleted in velo-cardio-facial syndrome, a congenital malformation syndrome, In addition, this gene locus is related to susceptibility to schizophrenia. The other type of hyperprolinemia is HPII. It is caused by a deficiency in P5C dehydrogenase activity. Hypoprolinemia, on the other hand, is found in the recently described deficiency of P5C synthetase. This enzyme defect leads to hyperammonemia associated with hypoornithinemia, hypocitrullinemia, and hypoargininemia other than hypoprolinemia. Hyperhydroxyprolinemia is an autosomal recessive inheritance disorder caused by the deficiency of hydroxyproline oxidase. There are nosymptoms and it is believed to be a benign metabolic disorder. The deficiency of ornithine aminotransferase causes transient hyperammonemia during early infancy due to deficiency of ornithine in the urea cycle. In later life, gyrate atrophy of the retina occurs due to hyperornithinemia, a paradoxical phenomenon. Finally, prolidase deficiency is a rare autosomal recessive hereditary disease. Prolidase catalyzes hydrolysis of dipeptide or oligopeptide with a C-terminal proline or hydroxyproline and its deficiency can cause mental retardation and severe skin ulcers.
引用
收藏
页码:2016S / 2020S
页数:5
相关论文
共 50 条
[1]   Early neurological phenotype in 4 children with biallelic PRODH mutations [J].
Afenjar, Alexandra ;
Moutard, Marie-Laure ;
Doummar, Diane ;
Guet, Agnes ;
Rabier, Daniel ;
Vermersch, Anne-Isabelle ;
Mignot, Cyril ;
Burglen, Lydie ;
Heron, Delphine ;
Thioulouse, Elizabeth ;
de Villemeur, Thierry Billette ;
Campion, Dominique ;
Rodriguez, Diana .
BRAIN & DEVELOPMENT, 2007, 29 (09) :547-552
[2]   Proline precursors to sustain mammalian collagen synthesis [J].
Barbul, Adrian .
JOURNAL OF NUTRITION, 2008, 138 (10) :2021S-2024S
[3]   Hyperammonemia with reduced ornithine, citrulline, arginine and proline:: a new inborn error caused by a mutation in the gene encoding Δ1-pyrroline-5-carboxylate synthase [J].
Baumgartner, MR ;
Hu, CAA ;
Almashanu, S ;
Steel, G ;
Obie, C ;
Aral, B ;
Rabier, D ;
Kamoun, P ;
Saudubray, JM ;
Valle, D .
HUMAN MOLECULAR GENETICS, 2000, 9 (19) :2853-2858
[4]   Functional consequences of PRODH missense mutations [J].
Bender, HU ;
Almashanu, S ;
Steel, G ;
Hu, CA ;
Lin, WW ;
Willis, A ;
Pulver, A ;
Valle, D .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (03) :409-420
[5]   Comparative aspects of tissue glutamine and proline metabolism [J].
Bertolo, Robert F. ;
Burrin, Douglas G. .
JOURNAL OF NUTRITION, 2008, 138 (10) :2032S-2039S
[6]   A human homologue of the Drosophila melanogaster sluggish-A (proline oxidase) gene maps to 22q11.2, and is a candidate gene for type-I hyperprolinaemia [J].
Campbell, HD ;
Webb, GC ;
Young, IG .
HUMAN GENETICS, 1997, 101 (01) :69-74
[7]   HYPERPROLINEMIA TYPE-II - EVIDENCE OF THE EXCRETION OF 3-HYDROXY DELTA-1-PYRROLINE 5-CARBOXYLIC ACID [J].
DOOLEY, KC ;
APPLEGARTH, DA .
CLINICAL BIOCHEMISTRY, 1979, 12 (02) :62-65
[9]  
ENDO F, 1989, J BIOL CHEM, V264, P4476
[10]   BIOCHEMICAL BASIS OF PROLIDASE DEFICIENCY - POLYPEPTIDE AND RNA PHENOTYPES AND THE RELATION TO CLINICAL PHENOTYPES [J].
ENDO, F ;
TANOUE, A ;
KITANO, A ;
ARATA, J ;
DANKS, DM ;
LAPIERE, CM ;
SEI, Y ;
WADMAN, SK ;
MATSUDA, I .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (01) :162-169